Mantle cell lymphoma trials in Brazil

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  Where

  Curitiba, Porto Alegre, Rio de Janeiro, Salvador, São Paulo

  Age

  18 years and over

  People

  182 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT06084936
• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  Where

  Barretos, Belo Horizonte, Campinas, Caxias do Sul, Curitiba, Joinville, Porto AlegreRS, Recife, São Paulo, Vitória

  Age

  18 years and over

  People

  300 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT06742996 · EU 2024-515593-27-00
• Phase 1/2Taking people
  A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

  Where

  São Paulo, Vitória

  Age

  18 years and over

  People

  258 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT06697184 · EU 2024-518829-15-00
• Phase 1/2Taking people
  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  Where

  Brasília, Curitiba, Porto Alegre, São Paulo

  Age

  18 years and over

  People

  689 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT05006716 · EU 2022-502157-33-00